DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20190161

Drug utilization research: a review

Dinesh Kumar Meena, M. Jayanthi

Abstract


Data from drug utilization research is an invaluable resource for all stake holders involved in drug and health policies. Drug utilization is “marketing, distribution, prescription and use of drugs in a society, with special emphasis on the resulting medical, social and economic consequences”. Research on drug utilization includes factors related to prescribing, dispensing, administering and intake of medication and its associated events. The ultimate purpose of drug utilization research is to estimate the optimal quality of drug therapy by identifying, documenting, analysing problems in drug utilization and monitoring the consequences. It encourages the prescribers to prescribe correct drug at appropriate dose and affordable price. It contributes to the knowledge of rational use of drugs in the society; whether the drug is being prescribed appropriately, whether the drug is taken in correct dosage, whether the drug is available at affordable price or misused. It provides valuable feedback about the rationality of the prescription to the doctors. It also assesses whether an intervention affects the drug use in the population by examining the outcomes of different types of intervention given to improve rationality in drug use. Drug utilization research can be qualitative or quantitative and can be done by various methods. This review highlights the understanding of various aspects, different designs and WHO guidelines for conducting drug utilization research.


Keywords


ATC classification, Aspects of drug utilization research, Drug utilization research, Defined daily dose, Drug use indicators, Drug and therapeutic committee

Full Text:

PDF

References


WHO policy perspectives in medicines. Promoting rational use of medicines: World Health Organization. 2002. Available at: http://www/who.int/medicines/publications/policyperspectives/ppm05en.pdf. Accessed 19 July 2018.

Foster S. Supply and use of essential drugs in sub-Saharan Africa: some issues and possible solutions. Social Sci Med. 1991 Jan 1;32(11):1201-18.

Bhatt AD. Drug promotion and doctor: a relationship under change?. J Postgrad Med. 1993 Jul 1;39(3):120.

Choudhry NK, Stelfox HT, Detsky AS. Relationship between authors of clinical practice guidelines and the pharmaceutical industry. JAMA. 2002; 287:612-7.

Drug Utilization Research: Methods and Applications, First Edition. Elseviers M, Wettermark B, Almarsdóttir AB, Andersen M, Benko R, Bennie M, et al, eds. John Wiley & Sons Ltd; 2016.

Truter I. A review of drug utilization studies and methodologies. Jordan J Pharmaceut Sci. 2008;1(2):91-103.

Laporte JR, Porta M, Capella DO. Drug utilization studies: a tool for determining the effectiveness of drug use. Br J Clin Pharmacol. 1983 Sep;16(3):301-4.

WHO. Introduction to Drug Utilization Research. 2003. Available at: http://apps.who.int/medicinedocs/pdf/s4876e/s4876e.pdf. Accessed 20 July 2018.

Sachdeva PD, Patel BG. Drug utilization studies-scope and future perspectives. Int J Pharmaceut Biol Res. 2010;1(1):11-7.

International Network for Rational Use of Drugs and World Health Organization. How to Investigate Drug use in Health Facilities: Selected drug use indicators. 1993. Available at: http://apps.who.int/medicinedocs/pdf/s2289e/s2289e.pdf. Accessed 23 July 2018.

WHO. How to investigate drug use in community: Guidelines for social science research. 1992. Available at: http://apps.who.int/iris/bitstream/handle/10665/61866/WHO_DAP_92.3.pdf?sequence=1&isAllowed=y. Accessed 17 July 2018.

Drug Use Evaluation-Participant’s Guide. 2007. Published by Management sciences for health and World Health Organization. 3-9. Available at: http://www.who.int/medicines/technical_briefing/tbs/Participant-s-Guide-All-Sessions.pdf. Accessed 12 September 2018.

WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2018. Oslo, Norway, 2017. Available at: https://www.whocc.no/filearchive/publications/guidelines.pdf. Accessed 12 September 2018.

WHO. Organization of Health Care in Developing Countries, Report of the conference of experts, the rational use of drugs, 1985, WHO. Geneva 1987.1-6. Available at: http://apps.who.int/medicinedocs/documents/s17054e/s17054e.pdf. Accessed 2 April 2018.

Trivedi JK, Dhyani M, Yadav VS, Rai SB. Anti-psychotic drug prescription pattern for schizophrenia: Observation from a general hospital psychiatry unit. Indian J Psychiatry. 2010 Jul 1;52(3):279.

Ramadas S, Kuttichira P, Sumesh TP, Ummer SA. A study of an antipsychotic prescription pattern of patients with schizophrenia in a developing country. Indian J Psychological Med. 2010 Jan;32(1):13-16.

Grover S, Kumar V, Avasthi A, Kulhara P. An audit of first prescription of new patients attending a psychiatry walk-in-clinic in north India. Indian J Pharmacol. 2012 May;44(3):319-25.

Patel Pinal D, Patel RK, Patel NJ. Analysis of prescription pattern and drug utilization in asthma therapy. Int Res J Pharm. 2012;3(7):257-60.

Srivastava R, Sharma S, Keshri L, Wal P. Assessment of prescription pattern in asthma therapy at Shamli hospitals. Rev Recent Clin Trials. 2012 May 1;7(2):158-66.

Pandey A, Tripathi P, Pandey RD. Prescription pattern in asthma therapy at Gorakhpur hospitals. Lung India. 2010;27:8-10.

Remesh A, Salim S, Gayathri AM, Nair U, Retnavally KG. Antibiotics prescribing pattern in the in-patient departments of a tertiary care hospital. Arch Pharmacy Pract. 2013 Apr 1;4(2):71-6.

Hazra A, Tripathi SK, Alam MS. Prescribing and dispensing activities at the health facilities of a non-governmental organization. National Med J India. 2000;13(4):177-82.

Mashalla Y, Setlhare V, Massele A, Sepako E, Tiroyakgosi C, Kgatlwane J, et al. Assessment of prescribing practices at the primary healthcare facilities in Botswana with an emphasis on antibiotics: Findings and implications. Int J Clin Pract. 2017 Dec;71(12):e13042.

Ab Rahman N, Teng CL, Sivasampu S. Antibiotic prescribing in public and private practice: a cross-sectional study in primary care clinics in Malaysia. BMC Infectious Dis. 2016 Dec;16(1):208.